iBio (IBIO) Change in Cash (2010 - 2026)
iBio (IBIO) posted quarterly Change in Cash of $19.0 million for Q1 2026, up 1022.13% year-over-year from $1.7 million in Q1 2025, and up 3279.5% quarter-over-quarter from $561000.0 in Q4 2025.
iBio (IBIO) Change in Cash (2010 - 2026) Analysis & Trends
iBio (IBIO) has reported Change in Cash for 17 consecutive years, with $19.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 1022.13% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $42.7 million (up 3516.89% YoY), while the FY2025 annual figure was -$5.6 million, down 182.28% from the prior year.
- Change in Cash climbed to $19.0 million in Q1 2026 per IBIO's latest filing, from $561000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $19.5 million in Q3 2025 and bottomed at -$12.8 million in Q3 2022.
- Historically, Change in Cash has averaged $159647.1 across 5 years, with a median of -$2.1 million in 2025.
- Annual changes were most pronounced in 2024 — Change in Cash tumbled 473.89% — and 2026, when it surged 1022.13%.
- iBio's Change in Cash stood at -$11.9 million in 2022, then soared by 94.13% to -$701000.0 in 2023, then sank by 473.89% to -$4.0 million in 2024, then soared by 113.94% to $561000.0 in 2025, then surged by 3279.5% to $19.0 million in 2026.
- Business Quant data shows IBIO's Change in Cash at $19.0 million in Q1 2026, $561000.0 in Q4 2025, and $19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 18.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.96 Mn |
| Dec 31, 2025 | 561,000.00 |
| Sep 30, 2025 | 19.55 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -3.16 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | -701,000.00 |
| Sep 30, 2023 | -2.82 Mn |
| Jun 30, 2023 | -2.20 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | -11.93 Mn |
| Sep 30, 2022 | -12.79 Mn |
| Jun 30, 2022 | -11.04 Mn |
| Mar 31, 2022 | -5.44 Mn |
| Dec 31, 2021 | -17.68 Mn |
| Sep 30, 2021 | -14.58 Mn |
| Jun 30, 2021 | -7.22 Mn |